Non-invasive tests-based risk stratification: Baveno VII and beyond
- PMID: 36417892
- PMCID: PMC9845674
- DOI: 10.3350/cmh.2022.0361
Non-invasive tests-based risk stratification: Baveno VII and beyond
Keywords: Hypertension; Liver cirrhosis; Portal elasticity imaging techniques.
Conflict of interest statement
The authors have no conflicts to disclose.
Figures
Comment in
-
Correspondence on Editorial regarding "Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients".Clin Mol Hepatol. 2023 Jan;29(1):188-190. doi: 10.3350/cmh.2022.0408. Epub 2022 Nov 22. Clin Mol Hepatol. 2023. PMID: 36642415 Free PMC article. No abstract available.
Comment on
-
Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients.Clin Mol Hepatol. 2023 Jan;29(1):135-145. doi: 10.3350/cmh.2022.0181. Epub 2022 Sep 5. Clin Mol Hepatol. 2023. PMID: 36064306 Free PMC article.
References
-
- Mandorfer M, Simbrunner B. Prevention of first decompensation in advanced chronic liver disease. Clin Liver Dis. 2021;25:291–310. - PubMed
-
- de Franchis R, Baveno VI Faculty Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–752. - PubMed
-
- Mandorfer M, Hernández-Gea V, García-Pagán JC, Reiberger T. Noninvasive diagnostics for portal hypertension: a comprehensive review. Semin Liver Dis. 2020;40:240–255. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
